CONGRUENT SOLUTIONS, INC. – Trademark Portfolio
Entity Type: 03
CONGRUENT SOLUTIONS, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include IPX, IPX RETIREMENT, INVESTMENT PROVIDER XCHANGE, and INVESTMENT PROVIDER XCHANGE (IPX). The owner is based in BURLINGTON, MA.
1500 DISTRICT AVENUE
BURLINGTON, MA 01803
Showing of trademarks Trademarks
Trademark Classifications
CONGRUENT SOLUTIONS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does CONGRUENT SOLUTIONS, INC. have?
CONGRUENT SOLUTIONS, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does CONGRUENT SOLUTIONS, INC. file in?
CONGRUENT SOLUTIONS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 36 (Insurance & Financial). Class 42 covers scientific and technological services; industrial analysis and research services.
What are CONGRUENT SOLUTIONS, INC.'s most well-known trademarks?
CONGRUENT SOLUTIONS, INC.'s registered trademark portfolio includes well-known marks such as IPX, IPX RETIREMENT, INVESTMENT PROVIDER XCHANGE, and INVESTMENT PROVIDER XCHANGE (IPX). These are among 5 currently registered trademarks in the portfolio.
What is CONGRUENT SOLUTIONS, INC.'s trademark registration success rate?
CONGRUENT SOLUTIONS, INC. has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.